Association of RAD51 with Homologous Recombination Deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial.
暂无分享，去创建一个
P. Fasching | A. Schneeweiss | C. Denkert | F. Marmé | P. Jank | V. Nekljudova | T. Karn | M. van Mackelenbergh | C. Schem | S. Loibl | E. Stickeler | E. Hahnen | V. Serra | S. Florian | J. Balmaña | D. Zahm | A. Llop-Guevara | V. Vladimirova | G. Villacampa | R. Dienstmann | A. Herencia-Ropero | M. V. van Mackelenbergh